Efficacy and safety of mirogabalin + opioids vs opioids alone for neuropathic cancer pain: Miro-Canp.
Saved in:
| Title: | Efficacy and safety of mirogabalin + opioids vs opioids alone for neuropathic cancer pain: Miro-Canp. |
|---|---|
| Authors: | Hashiguchi S; Department of Palliative Medicine, St. Marianna University School of Medicine, Kawasaki, Japan., Matsumoto Y; Department of Palliative Therapy, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan., Kessoku T; Department of Gastroenterology, International University of Health and Welfare, Chiba, Japan., Kajiura S; Department of Medical Oncology and Palliative Medicine, Toyama University Hospital, Toyama, Japan., Honma H; Department of Palliative Medicine, Niigata Cancer Center Hospital, Niigata, Japan., Yamaguchi T; Department of Palliative Medicine, Kobe University Graduate School of Medicine, Hyogo, Japan., Hasuo H; Department of Psychosomatic Medicine, Kansai Medical University, Osaka, Japan., Takahashi H; Primary Medical Science Department, Medical Affairs Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan., Yamamoto S; Data Intelligence Department, Global DX, Daiichi Sankyo Co., Ltd., Tokyo, Japan., Satomi E; Department of Palliative Medicine, National Cancer Center Hospital, Tokyo, Japan. |
| Source: | Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2026 Jan; Vol. 27 (1), pp. 65-75. Date of Electronic Publication: 2026 Feb 25. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study; Comparative Study |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 100897346 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7666 (Electronic) Linking ISSN: 14656566 NLM ISO Abbreviation: Expert Opin Pharmacother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
